• Citer

Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: The EORTC 1307-BCG/ BIG5–13/TESARO PR-30–50–10-C BRAVO Study

par Turner, Nicholas C;Balmaña, Judith;Poncet, Coralie;Goulioti, Theodora;Tryfonidis, Konstantinos;Honkoop, Aafke A.H.;Zoppoli, Gabriele;Razis, Evangelia;Johannsson, Oskar Th;Colleoni, Marco Angelo;Tutt, Andrew M;Audeh, William;Ignatiadis, Michail ;Mailliez, Audrey;Tredan, Olivier;Musolino, Antonino;Vuylsteke, Peter;Juan-Fita, Maria Jose;Macpherson, Iain R J;Kaufman, Bella;Manso, Luis;Goldstein, Lori L.J.;Ellard, Susan S.L.;Láng, István;Jen, Kai Yu;Adam, Virginie;Litière, Saskia;Erban, John;Cameron, David A
Référence Clinical cancer research, 27, 20, page (5482-5491)
Publication Publié, 2021-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: The EORTC 1307-BCG/ BIG5–13/TESARO PR-30–50–10-C BRAVO Study
Auteur:	Turner, Nicholas C; Balmaña, Judith; Poncet, Coralie; Goulioti, Theodora; Tryfonidis, Konstantinos; Honkoop, Aafke A.H.; Zoppoli, Gabriele; Razis, Evangelia; Johannsson, Oskar Th; Colleoni, Marco Angelo; Tutt, Andrew M; Audeh, William; Ignatiadis, Michail; Mailliez, Audrey; Tredan, Olivier; Musolino, Antonino; Vuylsteke, Peter; Juan-Fita, Maria Jose; Macpherson, Iain R J; Kaufman, Bella; Manso, Luis; Goldstein, Lori L.J.; Ellard, Susan S.L.; Láng, István; Jen, Kai Yu; Adam, Virginie; Litière, Saskia; Erban, John; Cameron, David A
Informations sur la publication:	Clinical cancer research, 27, 20, page (5482-5491)
Statut de publication:	Publié, 2021-10
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1078-0432
	info:doi/10.1158/1078-0432.CCR-21-0310
	info:scp/85117416618
	info:pmid/34301749